309 related articles for article (PubMed ID: 14562047)
1. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
[TBL] [Abstract][Full Text] [Related]
2. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
4. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function.
Gati A; Guerra N; Giron-Michel J; Azzarone B; Angevin E; Moretta A; Chouaib S; Caignard A
Cancer Res; 2001 Apr; 61(8):3240-4. PubMed ID: 11309272
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
Franciszkiewicz K; Le Floc'h A; Jalil A; Vigant F; Robert T; Vergnon I; Mackiewicz A; Benihoud K; Validire P; Chouaib S; Combadière C; Mami-Chouaib F
Cancer Res; 2009 Aug; 69(15):6249-55. PubMed ID: 19638592
[TBL] [Abstract][Full Text] [Related]
7. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells.
Dolstra H; Fredrix H; van der Meer A; de Witte T; Figdor C; van de Wiel-van Kemenade E
Bone Marrow Transplant; 2001 May; 27(10):1087-93. PubMed ID: 11438826
[TBL] [Abstract][Full Text] [Related]
8. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
Gati A; Guerra N; Gaudin C; Da Rocha S; Escudier B; Lécluse Y; Bettaieb A; Chouaib S; Caignard A
Cancer Res; 2003 Nov; 63(21):7475-82. PubMed ID: 14612548
[TBL] [Abstract][Full Text] [Related]
9. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
11. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
12. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
[TBL] [Abstract][Full Text] [Related]
13. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
14. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
[TBL] [Abstract][Full Text] [Related]
15. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas.
Zocchi MR; Ferrarini M; Rugarli C
Eur J Immunol; 1990 Dec; 20(12):2685-9. PubMed ID: 1702723
[TBL] [Abstract][Full Text] [Related]
16. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J
Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777
[TBL] [Abstract][Full Text] [Related]
17. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.
Hansasuta P; Dong T; Thananchai H; Weekes M; Willberg C; Aldemir H; Rowland-Jones S; Braud VM
Eur J Immunol; 2004 Jun; 34(6):1673-9. PubMed ID: 15162437
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
19. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
So T; Takenoyama M; Ichiki Y; Mizukami M; So T; Hanagiri T; Sugio K; Yasumoto K
Cancer; 2005 Jan; 103(1):200-8. PubMed ID: 15573370
[TBL] [Abstract][Full Text] [Related]
20. A human killer inhibitory receptor specific for HLA-A1,2.
Döhring C; Scheidegger D; Samaridis J; Cella M; Colonna M
J Immunol; 1996 May; 156(9):3098-101. PubMed ID: 8617928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]